SLN Overview
Upcoming Projects (SLN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SLN)
-
Discussing Silence Therapeutics' divesiran and Protagonist's rusfertide as potential therapies in Polycythemia Vera
Tickers: SLN, PTGX
Executed On: Jan 07, 2025 at 01:30 PM EST -
Discussing the 36-Week topline data from the Phase 2 Study of Silence Therapeutics' zerlasiran in Patients with High Lipoprotein(a)
Ticker: SLN
Executed On: Apr 24, 2024 at 03:30 PM EDT
Upcoming & Overdue Catalysts (SLN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SLN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
